Artivion Revenue and Competitors
Employee Data
- Artivion has 866 Employees.
- Artivion grew their employee count by 4% last year.
Artivion's People
Name | Title | Email/Phone |
---|
Artivion Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $1.7M | 11 | -8% | N/A | N/A |
#3 | $2.3M | 16 | 14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $17.1M | 110 | 5% | $0.07B | N/A |
#6 | $4M | 26 | -7% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | N/A | 866 | 4% | N/A | N/A |
#9 | $1.1M | 7 | 17% | N/A | N/A |
#10 | $7.8M | 50 | 2% | N/A | N/A |
What Is Artivion?
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. \n\nArtivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.
keywords:N/AN/A
Total Funding
866
Number of Employees
N/A
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $459.6M | 1132 | 6% | N/A |
#2 | $386.8M | 1156 | 7% | N/A |
#3 | $593.2M | 1284 | -7% | N/A |
#4 | $287.3M | 1464 | -20% | $101.3M |
#5 | $372.7M | 1836 | 1% | N/A |